---
figid: PMC7335982__apb-10-338-g006
figtitle: Signaling pathways and deregulation of its modalities such as Stat3/mTor,
  Hedgehog, Notch and Wnt/-catenin cascade defined as a new therapeutic strategy in
  the prevention of cancer extension, especially CSCs growth behaviors modification
  ()
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
pmcid: PMC7335982
filename: apb-10-338-g006.jpg
figlink: pmc/articles/PMC7335982/figure/F6/
number: F6
caption: Signaling pathways and deregulation of its modalities such as Stat3/mTor,
  Hedgehog, Notch and Wnt/-catenin cascade defined as a new therapeutic strategy in
  the prevention of cancer extension, especially CSCs growth behaviors modification
  (). Multiple aspects of cell signaling make this alternative so susceptible and
  targeting that kind of treatment item seems so difficult to utilize in the clinic.
  A lot of new generation drugs withdraw after several experimental and clinical trials,
  in terms of the complexity of signaling pathways., Mentioned signaling items directly
  involved in the developmental of the body during intra uterine life and similarity
  of normal stem cells to CSCs reveal more knowledge in both of them mutually. The
  notch signaling pathway and its cascade in multiple biological aspects finally affected
  CSCs stemness, MDR, and hypoxia inducible factor (HIF) pathway. On the intermediated
  modalities in this cascade such as γ-secretase inhibitors and antibodies directed
  showed accepted resulted in a clinical trial in various types of cancers. It is
  critical to know about the diversity of Notch signaling to manipulee of the final
  events in special cancer like breast cancers. Utilizing of Notch signaling inhibitors
  in oncology related to many alternatives such as type of cancer, exact pharmacodynamic
  effects identification and mechanistic understanding of it signaling. For example,
  CD44 as a biomarker in CSCs is Wnt signaling target and knockdown of CD44 diminished
  tumor formation. In another study administration of an antagonist of Wnt decreased
  mammosphere formation.
papertitle: Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological
  Concepts and Drug Delivery System Modification.
reftext: Zeynab Aaliyari-Serej, et al. Adv Pharm Bull. 2020 Jul;10(3):338-349.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9677472
figid_alias: PMC7335982__F6
figtype: Figure
redirect_from: /figures/PMC7335982__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7335982__apb-10-338-g006.html
  '@type': Dataset
  description: Signaling pathways and deregulation of its modalities such as Stat3/mTor,
    Hedgehog, Notch and Wnt/-catenin cascade defined as a new therapeutic strategy
    in the prevention of cancer extension, especially CSCs growth behaviors modification
    (). Multiple aspects of cell signaling make this alternative so susceptible and
    targeting that kind of treatment item seems so difficult to utilize in the clinic.
    A lot of new generation drugs withdraw after several experimental and clinical
    trials, in terms of the complexity of signaling pathways., Mentioned signaling
    items directly involved in the developmental of the body during intra uterine
    life and similarity of normal stem cells to CSCs reveal more knowledge in both
    of them mutually. The notch signaling pathway and its cascade in multiple biological
    aspects finally affected CSCs stemness, MDR, and hypoxia inducible factor (HIF)
    pathway. On the intermediated modalities in this cascade such as γ-secretase inhibitors
    and antibodies directed showed accepted resulted in a clinical trial in various
    types of cancers. It is critical to know about the diversity of Notch signaling
    to manipulee of the final events in special cancer like breast cancers. Utilizing
    of Notch signaling inhibitors in oncology related to many alternatives such as
    type of cancer, exact pharmacodynamic effects identification and mechanistic understanding
    of it signaling. For example, CD44 as a biomarker in CSCs is Wnt signaling target
    and knockdown of CD44 diminished tumor formation. In another study administration
    of an antagonist of Wnt decreased mammosphere formation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - smo
  - sm
  - hh
  - Gli
  - ci
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - arm
  - pan
  - l(3)87Bi
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - gli
  - ctnnb1
  - tap2b
  - elk4
  - apc
  - SMO
  - SMOX
  - GLI1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - HNF4A
  - APC
  - PROC
---
